SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-450398"
 

Search: onr:"swepub:oai:DiVA.org:uu-450398" > Impact of preoperat...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Impact of preoperative breast MRI on 10-year survival outcome of patients included in the Swedish randomized multicenter POMB trial

Gonzalez, Virginia (author)
Uppsala universitet,Centrum för klinisk forskning, Västerås
Arver, Brita (author)
Department of Oncology and Pathology, Karolinska Institutet
Löfgren, Lars (author)
Department of Surgery, S:t Goran Hospital
show more...
Bergkvist, Leif (author)
Uppsala universitet,Centrum för klinisk forskning, Västerås
Sandelin, Kerstin (author)
Department of Molecular Medicine and Surgery, Karolinska Institutet
Eriksson, Staffan (author)
Uppsala universitet,Centrum för klinisk forskning, Västerås
show less...
 (creator_code:org_t)
2021-10-06
2021
English.
In: BJS Open. - : Oxford University Press. - 2474-9842. ; 5:5
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • ABSTRACTBackground: The value of preoperative breast magnetic resonance imaging (MRI) as an adjunct technique regarding its effect on re-excision rates has been a subject of discussion. No survival data regarding preoperative breast MRI are available from randomized studies. Methods: Ten-year follow-up of the previous randomized multicentre study (POMB) was reported, evaluating MRI and its effect on disease-free survival (DFS) and overall survival (OS). A total of 440 patients with newly diagnosed breast cancer were randomized to either preoperative MRI (n = 220) group or conventional imaging (n = 220; control) group. Kaplan–Meier plots were used to analyze DFS and OS. Cox regression was used to estimate hazard ratios (HRs). Results: The median follow-up time for each group was 10 years. DFS rates were 85.5% and 80.0% for the MRI and control groups, respectively (P = 0.099). The risk of relapse or death was 46% higher in the control group (HR 1.46, 95% confidence interval 0.93–2.29). OS rates after 10 years were 90.9% and 88.6% for the MRI and control groups, respectively (P = 0.427). The risk of death was 27% higher in the control group (HR 1.27, 95% confidence interval 0.71–2.29). Locoregional, distant, and contralateral recurrence outcomes combined, were increased in the control group (P = 0.048). A subgroup analysis of patients with breast cancer stages I–III showed that preoperative MRI improved DFS compared with conventional imaging but this did not reach statistical significance (P = 0.057). Conclusion: After 10 years of follow-up, preoperative breast MRI as an adjunct to conventional imaging resulted in slightly, but non-significantly, improved DFS and OS.ClinicalTrials.gov Identifier: POMB NCT01859936

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

Bröstcancer
MRI
breast cancer
re-excision
MRI
survival
Surgery
Kirurgi
Oncology
Onkologi
Radiology
Radiologi

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • BJS Open (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view